Distinct Genomic Associations to Predict Acute Myeloid Leukemia (AML) Progression from Myelodysplastic Syndromes (MDS)

被引：0

作者：

Madanat, Yazan F. ^{[1
]}

Sekeres, Mikkael A. ^{[1
]}

Mukherjee, Sudipto ^{[1
]}

Al-Issa, Karam ^{[1
]}

Hirsch, Cassandra M. ^{[2
]}

Gerds, Aaron T. ^{[1
]}

Jha, Babal K. ^{[2
]}

Adema, Vera ^{[2
]}

Advani, Anjali ^{[1
]}

Nagata, Yasunobu ^{[2
]}

Kuzmanovic, Teodora ^{[2
]}

Carraway, Hetty E. ^{[1
]}

Przychodzen, Bartlomiej ^{[2
]}

Maciejewski, Jaroslaw P. ^{[2
]}

Nazha, Aziz ^{[1
]}

机构：

[1] Cleveland Clin, Taussig Canc Inst, Leukemia Program, Cleveland, OH 44106 USA

[2] Cleveland Clin, Translat Hematol & Oncol, Cleveland, OH 44106 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷

关键词：

MDS; genomics; molecular; leukemia; NGS;

D O I：

10.1016/j.clml.2018.07.172

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MDS-161

引用

页码：S261 / S261

页数：1

共 50 条

[1] Distinct Genomic Associations to Predict Acute Myeloid Leukemia (AML) Progression from Myelodysplastic Syndromes (MDS)
Madanat, Yazan F.
Sekeres, Mikkael A.
Al-Issa, Karam
Hirsch, Cassandra M.
Mukherjee, Sudipto
Gerds, Aaron T.
Abuhadra, Nour
Jha, Babal K.
Adema, Vera
Advani, Anjali S.
Nagata, Yasunobu
Kuzmanovic, Teodora
Przychodzen, Bartlomiej P.
Carraway, Hetty E.
Maciejewski, Jaroslaw P.
Nazha, Aziz
BLOOD, 2017, 130
[2] Diagnostic of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
Germing, Ulrich
Haferlach, Torsten
LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2015, 39 (05): : 291 - 299
[3] CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY
Steensma, D.
Abedi, M.
Bejar, R.
Cogle, C.
Foucar, K.
Garcia-Manero, G.
George, T.
Grinblatt, D.
Komrokji, R.
Maciejewski, J.
Pollyea, D.
Roboz, G.
Savona, M.
Scott, B.
Sekeres, M.
Thompson, M.
Sugrue, M.
Swern, A.
Nifenecker, M.
Erba, H.
LEUKEMIA RESEARCH, 2015, 39 : S124 - S124
[4] Molecular Epidemiologic Associations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) within the United States
Albitar, Adam Zrinski
Shah, Neil
McCloskey, James K.
Koprivnikar, Jamie L.
Zhao, Jianhua
Desai, Chirag
Sudarsanam, Sucha
Albitar, Maher
Lai, Catherine E.
BLOOD, 2018, 132
[5] Relationship of progression to acute myeloid leukemia (AML) from myelodysplastic syndrome (MDS) and cytogenetic status
Hellstrom-Lindberg, E.
Fenaux, P.
Mufti, G. J.
List, A. F.
Santini, V.
Gore, S.
Seymour, J. F.
Backstrom, J.
McKenzie, D.
Beach, C. L.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[6] HEXAMETHYLENE BISACETAMIDE (HMBA) IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
ANDREEFF, M
STONE, R
YOUNG, C
TONG, W
ERVIN, T
TAFURI, A
KOLITZ, J
RIFKIND, R
KUFE, D
MARKS, P
LEUKEMIA, 1991, 5 (02) : 174 - 174
[7] Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) following a diagnosis of breast cancer
Padmanabhan, A.
Block, A.
Sait, S.
Ford, L. A.
O'Connor, T. L.
Moysich, K. B.
Baer, M. R.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[8] MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIAS (AML) WITH MYELOFIBROSIS
IMBERT, M
NGUYEN, D
SULTAN, C
LEUKEMIA RESEARCH, 1992, 16 (01) : 51 - 54
[9] Population pharmacokinetic modelling of decitabine in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
Mistry, B.
Gibiansky, L.
Hussein, Z.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[10] Possible Biomarkers To Predict Response In Patients With Myelodysplastic Syndromes (MDS) Or Acute Myeloid Leukemia (AML) Treated With 5-Azacitidine
Kuendgen, Andrea
Mueller-Thomas, Catharina
Urbaniak, Petra
Lauseker, Michael
Haferlach, Torsten
Alpermann, Tamara
Albuquerque, Andreia
Kohlmann, Alexander
Schnittger, Susanne
Hildebrandt, Barbara
Royer-Pokora, Brigitte
Gattermann, Norbert
Haas, Rainer
Germing, Ulrich
Goetze, Katharina
BLOOD, 2013, 122 (21)

← 1 2 3 4 5 →